The death of a second teenage boy from liver failure caused by a gene therapy from Sarepta Therapeutics has left the Duchenne muscular dystrophy community angry, fearful, and divided over whether to maintain hope in the therapy.
Kameron Lawson learned about the boy’s death from a phone…